Skip to content

Nuo Therapeutics, Inc.: 10-K filed 2022-04-15

What Nuo Therapeutics, Inc. reported in its annual report filed 2022-04-15 (fiscal FY 2021): 40 published measures, 352 facts as tagged in accession 0001437749-22-009050.

This filing

Form
10-K (annual report)
Filed
2022-04-15
Fiscal period
fiscal FY 2021
Accession
0001437749-22-009050 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Nuo Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-12-311,465,918USD
At 2021-09-30149,930USD
At 2021-06-30153,085USD
At 2021-03-31157,264USD
At 2020-12-31161,432USD
At 2020-09-300USD
At 2020-06-3013USD
At 2020-03-3112,106USD
At 2019-12-31276,548USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-12-31673,079USD
At 2021-09-30672,467USD
At 2021-06-30668,871USD
At 2021-03-31666,504USD
At 2020-12-31664,951USD
At 2020-09-301,034,629USD
At 2020-06-301,019,163USD
At 2020-03-311,008,324USD
At 2019-12-311,485,666USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-12-31792,839USD
At 2021-09-30-522,537USD
At 2021-06-30-515,786USD
At 2021-03-31-509,240USD
At 2020-12-31-503,519USD
At 2020-09-30-1,034,629USD
At 2020-06-30-1,019,150USD
At 2020-03-31-996,218USD
At 2019-12-31-1,209,118USD
At 2018-12-31-81,987USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-12-311,414,569USD
At 2021-09-30148,430USD
At 2021-06-30151,585USD
At 2021-03-31157,264USD
At 2020-12-31161,432USD
At 2020-09-300USD
At 2020-06-3013USD
At 2020-03-3111,209USD
At 2019-12-3120,253USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-90,670USD365
2021-07-01 to 2021-09-30-6,751USD92
2021-01-01 to 2021-09-30-19,018USD273
2021-04-01 to 2021-06-30-6,546USD91
2021-01-01 to 2021-06-30-12,267USD181
2021-01-01 to 2021-03-31-5,721USD90
2020-01-01 to 2020-12-31-90,870USD366
2020-07-01 to 2020-09-30-15,479USD92
2020-01-01 to 2020-09-30142,988USD274
2020-04-01 to 2020-06-30-22,932USD91
2020-01-01 to 2020-06-30158,467USD182
2020-01-01 to 2020-03-31181,399USD91
2019-01-01 to 2019-12-31-1,194,894USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-119,955USD365
2021-01-01 to 2021-09-30-13,002USD273
2021-01-01 to 2021-06-30-9,847USD181
2021-01-01 to 2021-03-31-4,168USD90
2020-01-01 to 2020-12-31-53,821USD366
2020-01-01 to 2020-09-30-20,253USD274
2020-01-01 to 2020-06-30-20,240USD182
2020-01-01 to 2020-03-31-9,044USD91
2019-01-01 to 2019-12-31-921,674USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2020-01-01 to 2020-12-310USD366
2019-01-01 to 2019-12-310USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-12-311,373,092USD365
2019-01-01 to 2021-12-311,873,092USD1096
2021-01-01 to 2021-09-300USD273
2021-01-01 to 2021-06-300USD181
2021-01-01 to 2021-03-310USD90
2020-01-01 to 2020-12-31195,000USD366
2020-01-01 to 2020-09-300USD274
2020-01-01 to 2020-06-300USD182
2020-01-01 to 2020-03-310USD91
2019-01-01 to 2019-12-31305,000USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2021-01-01 to 2021-09-300USD273
2021-01-01 to 2021-06-300USD181
2021-01-01 to 2021-03-310USD90
2020-01-01 to 2020-12-310USD366
2020-01-01 to 2020-09-300USD274
2020-01-01 to 2020-06-300USD182
2020-01-01 to 2020-03-310USD91
2019-01-01 to 2019-12-310USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-12-31-23,593,069USD
At 2021-09-30-23,521,417USD
At 2021-06-30-23,514,666USD
At 2021-03-31-23,508,120USD
At 2020-12-31-23,502,399USD
At 2020-09-30-23,268,541USD
At 2020-06-30-23,253,062USD
At 2020-03-31-23,230,130USD
At 2019-12-31-23,411,529USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-01-01 to 2021-12-3130,296,376shares365
2021-07-01 to 2021-09-3030,258,744shares92
2021-01-01 to 2021-09-3030,258,744shares273
2021-04-01 to 2021-06-3030,258,744shares91
2021-01-01 to 2021-06-3030,258,744shares181
2021-01-01 to 2021-03-3130,258,744shares90
2020-01-01 to 2020-12-3125,692,248shares366
2020-07-01 to 2020-09-3024,247,400shares92
2020-01-01 to 2020-09-3024,152,874shares274
2020-04-01 to 2020-06-3024,247,400shares91
2020-01-01 to 2020-06-3024,105,092shares182
2020-01-01 to 2020-03-3123,962,785shares91
2019-01-01 to 2019-12-3123,722,400shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-01-01 to 2021-12-3130,296,376shares365
2021-07-01 to 2021-09-3030,258,744shares92
2021-01-01 to 2021-09-3030,258,744shares273
2021-04-01 to 2021-06-3030,258,744shares91
2021-01-01 to 2021-06-3030,258,744shares181
2021-01-01 to 2021-03-3130,258,744shares90
2020-01-01 to 2020-12-3127,312,176shares366
2020-07-01 to 2020-09-3024,247,400shares92
2020-01-01 to 2020-09-3026,310,807shares274
2020-04-01 to 2020-06-3024,247,400shares91
2020-01-01 to 2020-06-3027,353,849shares182
2020-01-01 to 2020-03-3130,460,299shares91
2019-01-01 to 2019-12-3123,722,400shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-0.03USD/shares365
2021-07-01 to 2021-09-300USD/shares92
2021-01-01 to 2021-09-300USD/shares273
2021-04-01 to 2021-06-300USD/shares91
2021-01-01 to 2021-06-300USD/shares181
2021-01-01 to 2021-03-310USD/shares90
2020-01-01 to 2020-12-310.3USD/shares366
2020-07-01 to 2020-09-300USD/shares92
2020-01-01 to 2020-09-300.01USD/shares274
2020-04-01 to 2020-06-300USD/shares91
2020-01-01 to 2020-06-300.01USD/shares182
2020-01-01 to 2020-03-310.01USD/shares91
2019-01-01 to 2019-12-31-0.05USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-0.03USD/shares365
2020-01-01 to 2020-12-310.27USD/shares366
2020-07-01 to 2020-09-300USD/shares92
2020-01-01 to 2020-09-30-0.01USD/shares274
2020-04-01 to 2020-06-300USD/shares91
2020-01-01 to 2020-06-30-0.01USD/shares182
2020-01-01 to 2020-03-31-0.01USD/shares91
2019-01-01 to 2019-12-31-0.05USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-300USD273
2021-04-01 to 2021-06-300USD91
2021-01-01 to 2021-06-300USD181
2021-01-01 to 2021-03-310USD90
2020-01-01 to 2020-12-310USD366
2020-07-01 to 2020-09-300USD92
2020-01-01 to 2020-09-300USD274
2020-04-01 to 2020-06-300USD91
2020-01-01 to 2020-06-300USD182
2020-01-01 to 2020-03-310USD91
2019-01-01 to 2019-12-310USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-12-310USD
At 2021-09-300USD
At 2021-06-300USD
At 2021-03-310USD
At 2020-12-310USD
At 2020-09-300USD
At 2020-06-300USD
At 2020-03-310USD
At 2019-12-310USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-12-3113,936USD365
2020-01-01 to 2020-12-31333,628USD366
2019-01-01 to 2019-12-3150,000USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-90,670USD365
2021-07-01 to 2021-09-30-6,751USD92
2021-01-01 to 2021-09-30-19,018USD273
2021-04-01 to 2021-06-30-6,546USD91
2021-01-01 to 2021-06-30-12,267USD181
2021-01-01 to 2021-03-31-5,721USD90
2020-01-01 to 2020-12-31-378,059USD366
2020-07-01 to 2020-09-30-6,254USD92
2020-01-01 to 2020-09-30-54,425USD274
2020-04-01 to 2020-06-30-5,793USD91
2020-01-01 to 2020-06-30-48,171USD182
2020-01-01 to 2020-03-31-42,378USD91
2019-01-01 to 2019-12-31-969,198USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-12-311,465,918USD
At 2021-09-30149,930USD
At 2021-06-30153,085USD
At 2021-03-31157,264USD
At 2020-12-31161,432USD
At 2020-09-300USD
At 2020-06-3013USD
At 2020-03-3112,106USD
At 2019-12-31276,548USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-12-31673,079USD
At 2021-09-30672,467USD
At 2021-06-30668,871USD
At 2021-03-31666,504USD
At 2020-12-31664,951USD
At 2020-09-301,034,629USD
At 2020-06-301,019,163USD
At 2020-03-311,008,324USD
At 2019-12-311,485,666USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-12-31526,557USD
At 2021-09-30525,945USD
At 2021-06-30522,349USD
At 2021-03-31519,982USD
At 2020-12-31518,429USD
At 2020-09-30536,044USD
At 2020-06-30529,803USD
At 2020-03-31536,103USD
At 2019-12-31538,669USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-01-01 to 2021-12-3190,670USD365
2021-07-01 to 2021-09-306,751USD92
2021-01-01 to 2021-09-3019,018USD273
2021-04-01 to 2021-06-306,546USD91
2021-01-01 to 2021-06-3012,267USD181
2021-01-01 to 2021-03-315,721USD90
2020-01-01 to 2020-12-31378,059USD366
2020-07-01 to 2020-09-306,254USD92
2020-01-01 to 2020-09-3054,425USD274
2020-04-01 to 2020-06-305,793USD91
2020-01-01 to 2020-06-3048,171USD182
2020-01-01 to 2020-03-3142,378USD91
2019-01-01 to 2019-12-311,000,761USD365

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-300USD273
2021-04-01 to 2021-06-300USD91
2021-01-01 to 2021-06-300USD181
2021-01-01 to 2021-03-310USD90
2020-01-01 to 2020-12-310USD366
2020-07-01 to 2020-09-300USD92
2020-01-01 to 2020-09-300USD274
2020-04-01 to 2020-06-300USD91
2020-01-01 to 2020-06-300USD182
2020-01-01 to 2020-03-310USD91
2019-01-01 to 2019-12-3131,563USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-300USD273
2021-04-01 to 2021-06-300USD91
2021-01-01 to 2021-06-300USD181
2021-01-01 to 2021-03-310USD90
2020-01-01 to 2020-12-310USD366
2020-07-01 to 2020-09-300USD92
2020-01-01 to 2020-09-300USD274
2020-04-01 to 2020-06-300USD91
2020-01-01 to 2020-06-300USD182
2020-01-01 to 2020-03-310USD91
2019-01-01 to 2019-12-31181,185USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-12-3137,124,205shares
At 2021-09-3030,258,744shares
At 2021-06-3030,258,744shares
At 2021-03-3130,258,744shares
At 2020-12-3130,258,744shares
At 2020-09-3024,247,400shares
At 2020-06-3024,247,400shares
At 2020-03-3124,247,400shares
At 2019-12-3123,722,400shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-12-3124,382,195USD
At 2021-09-3022,995,854USD
At 2021-06-3022,995,854USD
At 2021-03-3122,995,854USD
At 2020-12-3122,995,854USD
At 2020-09-3022,231,484USD
At 2020-06-3022,231,484USD
At 2020-03-3122,231,484USD
At 2019-12-3122,200,036USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2021-12-310USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-12-31146,522USD
At 2021-09-30146,522USD
At 2021-06-30146,522USD
At 2021-03-31146,522USD
At 2020-12-31146,522USD
At 2020-09-30163,189USD
At 2020-06-30163,189USD
At 2020-03-31163,189USD
At 2019-12-31173,189USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-12-3151,349USD
At 2021-09-301,500USD
At 2021-06-301,500USD
At 2021-03-310USD
At 2020-12-310USD
At 2020-09-300USD
At 2020-06-300USD
At 2020-03-31897USD
At 2019-12-3136,295USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-90,670USD365
2021-07-01 to 2021-09-30-6,751USD92
2021-01-01 to 2021-09-30-19,018USD273
2021-04-01 to 2021-06-30-6,546USD91
2021-01-01 to 2021-06-30-12,267USD181
2021-01-01 to 2021-03-31-5,721USD90
2020-01-01 to 2020-12-31-90,870USD366
2020-07-01 to 2020-09-30-15,479USD92
2020-01-01 to 2020-09-30142,988USD274
2020-04-01 to 2020-06-30-22,932USD91
2020-01-01 to 2020-06-30158,467USD182
2020-01-01 to 2020-03-31181,399USD91
2019-01-01 to 2019-12-31-1,194,894USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2021-01-01 to 2021-12-31-886,262USD365
2020-01-01 to 2020-12-317,708,824USD366
2020-01-01 to 2020-09-30142,988USD274
2020-01-01 to 2020-06-30158,467USD182
2020-01-01 to 2020-03-31181,399USD91
2019-01-01 to 2019-12-31-1,194,894USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-01-01 to 2021-12-3190,670USD365
2021-07-01 to 2021-09-306,751USD92
2021-01-01 to 2021-09-3019,018USD273
2021-04-01 to 2021-06-306,546USD91
2021-01-01 to 2021-06-3012,267USD181
2021-01-01 to 2021-03-315,721USD90
2020-01-01 to 2020-12-31378,059USD366
2020-07-01 to 2020-09-306,254USD92
2020-01-01 to 2020-09-3054,425USD274
2020-04-01 to 2020-06-305,793USD91
2020-01-01 to 2020-06-3048,171USD182
2020-01-01 to 2020-03-3142,378USD91
2019-01-01 to 2019-12-31789,119USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2020-01-01 to 2020-12-310USD366
2019-01-01 to 2019-12-3189,859USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-300USD273
2021-04-01 to 2021-06-300USD91
2021-01-01 to 2021-06-300USD181
2021-01-01 to 2021-03-310USD90
2020-01-01 to 2020-12-310USD366
2019-01-01 to 2019-12-31-4,237USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2021-01-01 to 2021-12-3121,048USD365
2020-01-01 to 2020-12-3124,203USD366
2019-01-01 to 2019-12-31311,164USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2021-01-01 to 2021-09-300USD273
2021-01-01 to 2021-06-300USD181
2021-01-01 to 2021-03-310USD90
2020-01-01 to 2020-12-310USD366
2020-01-01 to 2020-09-300USD274
2020-01-01 to 2020-06-300USD182
2020-01-01 to 2020-03-310USD91
2019-01-01 to 2019-12-3169,000USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2020-01-01 to 2020-12-31195,000USD366
2020-10-01 to 2020-10-31195,000USD31
2019-01-01 to 2019-12-310USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2020-01-01 to 2020-12-310USD366
2019-01-01 to 2019-12-31-22,170USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-12-310USD365
2020-01-01 to 2020-12-310USD366
2019-01-01 to 2019-12-31-25,348USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-12-318,128USD365
2021-01-01 to 2021-09-307,516USD273
2021-01-01 to 2021-06-303,920USD181
2021-01-01 to 2021-03-311,553USD90
2020-01-01 to 2020-12-31-29,520USD366
2020-01-01 to 2020-09-30-2,625USD274
2020-01-01 to 2020-06-30-8,866USD182
2020-01-01 to 2020-03-31-2,566USD91
2019-01-01 to 2019-12-31101,344USD365

Inspect the source

Entity
Nuo Therapeutics, Inc. / CIK 0001091596
Captured
2026-09-20T05:21:57.848Z
SEC response SHA-256
f9d1094a0912aec87dd50c0e6f3c9b7f90d3de5f7435cbf00ae5d71aa22d4723

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001091596.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))